Bone Morphogenetic Protein Type IB Receptor in Malignant Glioma
Author Information
Author(s): N Yamada, M Kato, P ten Dijkel, H Yamashita, TK Sampath, C-H Heldin, K Miyazono, K Funa
Primary Institution: Ludwig Institute for Cancer Research
Hypothesis
Do bone morphogenetic protein receptors play a role in the pathogenesis of malignant gliomas?
Conclusion
The study found that BMPR-IB is significantly increased in malignant glioma compared to low-grade astrocytomas and gliosis, suggesting a functional role for BMPs in these tumors.
Supporting Evidence
- BMPR-IB was significantly increased in malignant glioma compared to low-grade astrocytomas.
- ActR-I staining was weakly expressed in malignant glioma tumors.
- OP-1 was expressed in nervous tissue and detected in anaplastic areas of malignant glioma.
Takeaway
This study looked at how certain proteins are found in brain tumors and found that one type of protein is more common in the bad tumors than in the less serious ones.
Methodology
The study used immunohistochemical techniques to analyze tissue specimens from glioma and gliosis cases.
Participant Demographics
The study included 16 cases of human glioma and 5 cases of non-tumorous gliosis tissue.
Statistical Information
P-Value
p<0.005
Statistical Significance
p<0.001
Want to read the original?
Access the complete publication on the publisher's website